Salesforce enters its August 26 earnings window with a fresh Morgan Stanley downgrade reshaping the conversation — even as short sellers quietly retreat and the stock has clawed back some ground.
The analyst move is the week's standout. Morgan Stanley's Keith Weiss cut the rating from Overweight to Equal-Weight on July 21, slashing his target from $287 to $185. That's a bellwether firm moving to the sidelines with a target that sits only marginally above the current $170.06 close. CLSA initiated the same day at Hold with a $165 target — effectively flagging near-term downside. The two actions landed within hours of each other and tighten the ceiling considerably. Evercore ISI kept its Outperform but trimmed to $250 from $260 a week earlier, while Keybanc dropped to Sector Weight in early July. The direction of travel is clear: analysts who were buyers are stepping back. The consensus remains nominally Hold, with a mean target of $241 — but that figure is being dragged down fast, and the gap between Street optimism and ground-level action has rarely looked wider.
The short story has actually moved in the opposite direction, and that contrast matters. Bears covered aggressively this week: short interest fell 8% over the past five days to around 42.8 million shares, or 4.5% of free float. That reverses the rebuild flagged in the previous note, when SI had climbed back toward 47 million after a sharp June unwind from above 60 million shares. The borrow market reinforces the message that short positioning is not under stress. Cost to borrow is negligible at 0.41%, barely changed on the week, and availability is extraordinary — shares available to lend are running at roughly 24 times estimated short interest. There is no squeeze pressure, and no scarcity that would deter new shorts from entering. The short-score has eased to 39.7 from a recent peak near 41.8 on July 14, consistent with a positioning picture that is becoming less crowded rather than more.
Options have edged into mildly cautious territory. The put/call ratio at 0.77 is about 1.45 standard deviations above its 20-day average of 0.73 — not extreme, but the highest reading in several weeks. The 52-week range runs from 0.52 to 0.88, so the current level is in the upper third without being at a panic reading. Options traders are buying incremental downside protection, which aligns with the analyst sentiment shift but stops well short of a hedging rush.
The bull and bear cases are unusually well-defined right now. Bulls point to a dramatic value re-rating — the trailing P/E has compressed from roughly 35x in January to around 11x today, and price-to-FCF has collapsed from over 100x to around 23x. That repricing makes CRM look cheap relative to its own history, and the Agentforce and Fin acquisition narrative gives long-term holders a growth story to hold onto. Bears counter that cRPO growth has slipped to single digits in constant currency, enterprise AI spending is decelerating, and the heavy acquisition pace raises integration questions. Factor scores capture the ambiguity: analyst recommendation divergence ranks in the 98th percentile — meaning the spread between bulls and bears is wider than almost any other stock in the universe — while near-term EPS momentum sits only in the 42nd percentile.
Earnings history adds one more layer. The May 28 print delivered a 7.7% one-day gain and a 6.3% five-day follow-through — a clean beat. The prior quarter produced a small one-day dip of 1.6% that recovered to a 6.4% gain over five days. Two consecutive prints where the five-day move was meaningfully positive even when the day-one reaction was flat. The August 26 release is therefore less about whether Salesforce can beat near-term estimates — which have already been cut — and more about whether management's Agentforce monetization commentary is credible enough to offset a Street that is rapidly losing patience with the timeline.
See the live data behind this article on ORTEX.
Open CRM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
